Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

INTRODUCTION: Ketamine exhibits antidepressant properties in treatment-resistant depression (TRD) with some concern over its cardiovascular safety and tolerability issues. This paper reports on the cardiovascular safety in short-term intravenous ketamine treatment in TRD inpatients with major depres...

Descripción completa

Detalles Bibliográficos
Autores principales: Szarmach, Joanna, Cubała, Wiesław Jerzy, Włodarczyk, Adam, Gałuszko-Węgielnik, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605942/
https://www.ncbi.nlm.nih.gov/pubmed/33154641
http://dx.doi.org/10.2147/NDT.S273287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605942/
https://www.ncbi.nlm.nih.gov/pubmed/33154641
http://dx.doi.org/10.2147/NDT.S273287

Ejemplares similares